Projects per year
Personal profile
Education
- 1981 Ph.D., Biochemistry, Lille Science and Technology University, France
- 1977 Master of Science, Biochemistry, Lille Science and Technology University, France
- 1976 Bachelor of Science, Lille Science and Technology University, France
Experience
- 2020.01- Professor, Ph.D. Program in Neuroscience of Cognition and Consciousness, Taipei Medical University
- 2018.02- Professor, International Ph.D Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2017.10- Vice Dean, College of Biomedical Engineering, Taipei Medical University
- 2016.08- Director International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University
- 2015.08- Professor, Graduate Institute of Biomaterials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University
- 2014- Treasurer, Working Party on Cellular Therapies, International Society of Blood Transfusion
- 2012- Organising Committee member of the Working Party of Global Blood Safety, International Society of Transfusion Medicine
- 2013.08-2015 Director, Graduate Institute of Biomaterials and Tissue Engineering, College of Oral Medicine, Taipei Medical University
- 2012.08-2015 Professor, Graduate Institute of Biomaterials and Tissue Engineering, College of Oral Medicine, Taipei Medical University
- 2008.08- Taipei Medical University, Taipei, Taiwan
- 2008.08-2012.08 Visiting Professor, Graduate Institute of Medical Sciences, College of Oral Medicine ; “Foreign Expert” laureate from the National Science Council (NSC) of Taiwan
- 1998.01-2012 Human Protein Process Sciences, Lille, France
- Director
- Expert and International Consultant for Process and Biological product development (human blood & plasma products, recombinant products, animal-derived antisera); supervises research and development work on biological products
- World Health Organization Expert
- 1995.09-1997.12 Haemonetics Corporation, Boston, Ma., USA
- Vice President, Haemonetics Corporation, Boston, USA
- Director, Haemonetics Plasma product Services (HPPS), Nyon, Switzerland
- Member of the International Management Committee
- 1994.06-1995.09 Laboratoire Français du Fractionnement et des Biotechnologies (French National Plasma Fractionation and Biotechnology Laboratory), Paris, France
- 1995.01-1995.09 National Scientific Director (120 researchers and assistants)
- 1995.01 General Manager, Lille plasma fractionation plant (280 employees)
- Member of the Executive Committee, International Committee, and Scientific Committee
- 1986.09-1994.06 Regional Blood Transfusion Center - Lille - CRTS-Lille, France
- 1990 Director, plasma fractionation centre (150 employees)
- 1986 Chief of Department, plasma fractionation service (350 employees)
- Member of the Executive Committee
- 1984.10-1986.09 Regional Blood Transfusion Center - Lille - CRTS-Lille, France
- Chief of Research and Development laboratory
- 1982.05-1984.10 Northern Regional Research Center, USDA, Peoria, Illinois, USA
- Post-doctoral Research Assistant (University of Nebraska, Lincoln, USA), based at the Northern Regional Research Centre, IL., USA
Awards
- 2019 Award from the International Plasma Fractionation Association
-
Outstanding research papers award in 106 academic year
- Award for Recruitment and Retention of Special and Outstanding Talents by MOST in 106 academic year
- Outstanding research papers award in 105 academic year
- Excellent Teacher Award in 105 academic year
Research Interests
- Platelet growth factors for regenerative medicine and cell therapy
- Plasma fractionation
- Viral inactivation technologies
- Blood biotechnology
URL
Fingerprint
Dive into the research topics where Thierry Pierre Robert Burnouf is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
-
研究凝血酶/近紅外光應答結合抗凝血磺酸化胜肽載體於模擬血栓晶片的循環流場中之作用效益
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
血小板奈米粒子作為抗癌藥物之標靶傳輸系統
1/1/21 → 12/31/21
Project: A - Government Institution › a - National Health Research Institutes
-
研究凝血酶/近紅外光應答結合抗凝血磺酸化胜肽載體於模擬血栓晶片的循環流場中之作用效益
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
探討新穎性血小板奈米囊泡作為遞送神經生物分子載具於腦部再生之應用(3/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
血小板奈米粒子作為抗癌藥物之標靶傳輸系統
1/1/20 → 12/31/20
Project: A - Government Institution › a - National Health Research Institutes
Research output
-
Chemoradiotherapy for Inoperable Carotid Body Leiomyosarcoma: A Case Report and Review of Literature
Liu, C. S., Tsai, J. R., Kao, Y. T., Lu, L. S., Chen, Y. J., Burnouf, T., Wang, P. Y., Chiou, J. F. & Ting, L. L., Feb 11 2021, In: Frontiers in Oncology. 10, 599403.Research output: Contribution to journal › Article › peer-review
Open Access -
Guidance for the Procurement of COVID-19 Convalescent Plasma: Differences between High and Low-Middle Income Countries
Bloch, E. M., Goel, R., Wendel, S., Burnouf, T., Al-Riyami, A. Z., Ang, A. L., DeAngelis, V., Dumont, L. J., Land, K., Lee, C. K., Oreh, A., Patidar, G., Spitalnik, S. L., Vermeulen, M., Hindawi, S., Van den Berg, K., Tiberghien, P., Vrielink, H., Young, P., Devine, D. & 1 others, , Jan 2021, In: Vox Sanguinis. 116, 1, p. 18-35 18 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus) -
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic
Wendel, S., Land, K., Devine, D. V., Daly, J., Bazin, R., Tiberghien, P., Lee, C. K., Arora, S., Patidar, G. K., Khillan, K., Smid, W. M., Vrielink, H., Oreh, A., Al-Riyami, A. Z., Hindawi, S., Vermeulen, M., Louw, V., Burnouf, T., Bloch, E. M., Goel, R. & 2 others, , 2021, (Accepted/In press) In: Vox Sanguinis.Research output: Contribution to journal › Article › peer-review
-
Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety
Epstein, J., Smid, W. M., Wendel, S., Somuah, D. & Burnouf, T., Jan 2021, In: Vox Sanguinis. 116, 1, p. 13-14 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access8 Citations (Scopus) -
Clinical-grade cryopreserved doxorubicin-loaded platelets: Role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. W., Huang, C. C., Changou, C. A., Lu, L. S., Goubran, H. & Burnouf, T., Mar 23 2020, In: Journal of Biomedical Science. 27, 1, p. 45 45.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
Additional file 7 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017397.v1, https://springernature.figshare.com/articles/Additional_file_7_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017397/1
Dataset
-
Additional file 2 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017382.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017382/1
Dataset
-
Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.c.4903896.v1, https://springernature.figshare.com/collections/Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/4903896/1
Dataset
-
Additional file 5 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017391.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017391/1
Dataset
-
Additional file 4 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017388.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017388/1
Dataset